Running head JUBLIA1JUBLIA2JubliaChambe.docxwlynn1
Running head: JUBLIA 1
JUBLIA 2
Jublia
Chamberlain College of Nursing
NR-293, Pharmacology
Linda Le
Professor Ward
February 14, 2019
Jublia
This brochure has been designed to inform the people about the use of Efinaconazole for the treatment of onychomycosis. Onychomycosis is known as a fungal infection of the nail. This is targeted to educate the people on the treatment and use of Jublia as a toenail treatment. The brochure explains a small intro of necessary information regarding medicine like drug class, mechanism of action, and treat guide. The side effects and interactions are also explained. This is designed to provide awareness to layman regarding toenail infections.
References
Elewski, B. E., Rich, P., Pollak, R., Pariser, D. M., Watanabe, S., Senda, H., ... & Oli n, J. T. (2013).
Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III
multicenter, randomized, double-blind studies. Journal of the American Academy of
Dermatology, 68(4), 600-608.
Tschen, E. H., Bucko, A. D., Oizumi, N., Kawabata, H., Olin, J. T., & Pillai, R. (2013).
Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter,
randomized, double-blind study. J Drugs Dermatol, 12(2), 186-92.
RentSilverSpring.xlsx
DATASize (Square feet) Rent ($)52411106161175666119083014104501210550122578014808151490107014956101680835181066016255901469675139574411508201140912122062814346451519840110580011308041250950144980011687871224960139175011456901093840135385015309651650106017406651235775155096015458271583655157553513106251195749120063411856411444860138574012755931050880165089513406921560
Starbucks.xlsx
DATATearViscosityPressurePlate Gap0.00350.00180.000.000.00350.00170.000.000.45319.00186.001.800.85380.00174.001.800.35350.00180.000.000.30300.00180.000.000.70400.00180.000.001.90350.00190.000.000.25350.00180.000.000.10319.00186.00-1.800.15380.00186.00-1.803.90350.00180.003.000.00380.00174.00-1.800.55350.00180.000.000.00350.00180.00-3.000.05319.00174.00-1.800.40319.00174.001.804.30380.00186.001.800.00350.00180.000.00
VinhoVerde.xlsx
DATAFixed AcidityVolatile AcidityCitric AcidResidual SugarChloridesFree Sulfur DioxideTotal Sulfur DioxideDensitypHSulphatesAlcoholQuality11.50.30.620.06712270.99813.110.9710.167.70.7150.012.10.06431430.993713.410.5711.8610.40.5750.612.60.076112413.160.69959.20.630.212.70.09729650.99883.280.589.657.90.350.463.60.07815370.99733.350.8612.888.90.7450.182.50.07715480.997393.20.479.767.60.510.242.40.0918380.9983.470.669.6610.80.50.462.50.0735271.00013.050.649.556.40.470.42.40.0718190.99633.560.7310.669.90.630.242.40.0776330.99743.090.579.456.90.68502.50.10522370.99663.460.5710.667.30.450.365.90.07412870.99783.330.8310.556.80.810.0520.076140.995623.510.6610.867.50.510.021.70.08413310.995383.360.5410.5610.40.340.583.70.1746160.9973.190.711.367.10.460.142.80.07615370.996243.360.4910.759.10.50.31.90.0658170.997743.320.7110.567.30.690.322.20.069351040.996323..
2nd Annual Bioequivalence and Bioavailability Studies 2011 - AgendaPharma IQ
2nd Annual Bioequivalence and Bioavailability Studies - Full Agenda
LEARN MORE
http://www.bioequivalenceevent.com/redForms.aspx?id=532198&pdf_form=1?&shownewswindow=1&utm_source=PharmaIQ&utm_medium=SMO&mac=PMIQ_Slideshare&utm_campaign=Slideshare&utm_term=pdf
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
Dear students get fully solved assignments
Send your semester & Specialization name to our mail id :
help.mbaassignments@gmail.com
or
call us at : 08263069601
Anne Beal’s resume.
Working since ten years in the field of ophthalmic optics (Business to Consumer) in France and in Austria, I acquired a detailed and structured experience of the entire marketing chain; From glasses and contact lenses adaptation to after-sales enquiries, including purchasing and sales responsibilities.
Now relocated in Singapore, my goal is to leverage on my strong technical expertise and B2C knowledge to efficiently contribute in the business of the Healthcare sector, preferably Ophthalmic Optics.
Motivated to grow in Sales and Marketing, I would also positively consider opportunities in R&D, Production or Quality.
Specialties
* Extensive knowledge and understanding in the business of ophthalmic optics (B2C); Marketing, Purchasing, Sales, Logistics
* Refraction, Retinoscopy, Biomicroscopy, Biometrics, Keratometry
* Effective decision maker and excellent problem solving skill
* Capable of leadership, excellent team work and corporate attitude
* Experienced in customer relation, comfortable with international and multicultural environments
* Professional working proficiency in French, English and German
The Infection Control Practitioner is responsible for implementing and maintaining the multiple facets of the Infection Control Program of the Methodist Hospital. He/she is a liaison between all departments and the Infection Prevention and Control Committee. This individual maintains a routine surveillance program of patients, personnel, and the environmental problems that present a real or potential threat to the welfare of patients, visitors, or personnel throughout the institution. Send resumes to pchavez3@houstonmethodist.org.
Running head JUBLIA1JUBLIA2JubliaChambe.docxwlynn1
Running head: JUBLIA 1
JUBLIA 2
Jublia
Chamberlain College of Nursing
NR-293, Pharmacology
Linda Le
Professor Ward
February 14, 2019
Jublia
This brochure has been designed to inform the people about the use of Efinaconazole for the treatment of onychomycosis. Onychomycosis is known as a fungal infection of the nail. This is targeted to educate the people on the treatment and use of Jublia as a toenail treatment. The brochure explains a small intro of necessary information regarding medicine like drug class, mechanism of action, and treat guide. The side effects and interactions are also explained. This is designed to provide awareness to layman regarding toenail infections.
References
Elewski, B. E., Rich, P., Pollak, R., Pariser, D. M., Watanabe, S., Senda, H., ... & Oli n, J. T. (2013).
Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III
multicenter, randomized, double-blind studies. Journal of the American Academy of
Dermatology, 68(4), 600-608.
Tschen, E. H., Bucko, A. D., Oizumi, N., Kawabata, H., Olin, J. T., & Pillai, R. (2013).
Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter,
randomized, double-blind study. J Drugs Dermatol, 12(2), 186-92.
RentSilverSpring.xlsx
DATASize (Square feet) Rent ($)52411106161175666119083014104501210550122578014808151490107014956101680835181066016255901469675139574411508201140912122062814346451519840110580011308041250950144980011687871224960139175011456901093840135385015309651650106017406651235775155096015458271583655157553513106251195749120063411856411444860138574012755931050880165089513406921560
Starbucks.xlsx
DATATearViscosityPressurePlate Gap0.00350.00180.000.000.00350.00170.000.000.45319.00186.001.800.85380.00174.001.800.35350.00180.000.000.30300.00180.000.000.70400.00180.000.001.90350.00190.000.000.25350.00180.000.000.10319.00186.00-1.800.15380.00186.00-1.803.90350.00180.003.000.00380.00174.00-1.800.55350.00180.000.000.00350.00180.00-3.000.05319.00174.00-1.800.40319.00174.001.804.30380.00186.001.800.00350.00180.000.00
VinhoVerde.xlsx
DATAFixed AcidityVolatile AcidityCitric AcidResidual SugarChloridesFree Sulfur DioxideTotal Sulfur DioxideDensitypHSulphatesAlcoholQuality11.50.30.620.06712270.99813.110.9710.167.70.7150.012.10.06431430.993713.410.5711.8610.40.5750.612.60.076112413.160.69959.20.630.212.70.09729650.99883.280.589.657.90.350.463.60.07815370.99733.350.8612.888.90.7450.182.50.07715480.997393.20.479.767.60.510.242.40.0918380.9983.470.669.6610.80.50.462.50.0735271.00013.050.649.556.40.470.42.40.0718190.99633.560.7310.669.90.630.242.40.0776330.99743.090.579.456.90.68502.50.10522370.99663.460.5710.667.30.450.365.90.07412870.99783.330.8310.556.80.810.0520.076140.995623.510.6610.867.50.510.021.70.08413310.995383.360.5410.5610.40.340.583.70.1746160.9973.190.711.367.10.460.142.80.07615370.996243.360.4910.759.10.50.31.90.0658170.997743.320.7110.567.30.690.322.20.069351040.996323..
2nd Annual Bioequivalence and Bioavailability Studies 2011 - AgendaPharma IQ
2nd Annual Bioequivalence and Bioavailability Studies - Full Agenda
LEARN MORE
http://www.bioequivalenceevent.com/redForms.aspx?id=532198&pdf_form=1?&shownewswindow=1&utm_source=PharmaIQ&utm_medium=SMO&mac=PMIQ_Slideshare&utm_campaign=Slideshare&utm_term=pdf
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
Dear students get fully solved assignments
Send your semester & Specialization name to our mail id :
help.mbaassignments@gmail.com
or
call us at : 08263069601
Anne Beal’s resume.
Working since ten years in the field of ophthalmic optics (Business to Consumer) in France and in Austria, I acquired a detailed and structured experience of the entire marketing chain; From glasses and contact lenses adaptation to after-sales enquiries, including purchasing and sales responsibilities.
Now relocated in Singapore, my goal is to leverage on my strong technical expertise and B2C knowledge to efficiently contribute in the business of the Healthcare sector, preferably Ophthalmic Optics.
Motivated to grow in Sales and Marketing, I would also positively consider opportunities in R&D, Production or Quality.
Specialties
* Extensive knowledge and understanding in the business of ophthalmic optics (B2C); Marketing, Purchasing, Sales, Logistics
* Refraction, Retinoscopy, Biomicroscopy, Biometrics, Keratometry
* Effective decision maker and excellent problem solving skill
* Capable of leadership, excellent team work and corporate attitude
* Experienced in customer relation, comfortable with international and multicultural environments
* Professional working proficiency in French, English and German
The Infection Control Practitioner is responsible for implementing and maintaining the multiple facets of the Infection Control Program of the Methodist Hospital. He/she is a liaison between all departments and the Infection Prevention and Control Committee. This individual maintains a routine surveillance program of patients, personnel, and the environmental problems that present a real or potential threat to the welfare of patients, visitors, or personnel throughout the institution. Send resumes to pchavez3@houstonmethodist.org.
1. L OOKING FOR AN INTERNSHIP IN CLINICAL
Mélanie Tilte DEVELOPEMENT
S KILLS
Well organized.
Good adaptability to new situations.
Good communication with people, used to working in team.
E MPLOYMENT
January-March 2012: Pharmacist in Cytotoxic’s manufacturing unit
Pharmacie Centrale CHRU , Lille (France)
Follow-up of patients record, for formal treatments and clinical trials
Training in the clean room
October-December 2011: Pharmacist in Respiratory emergency and
intensive care unit
Hospital Calmette , Lille (france)
In charge of an audit about antibiotherapies
Summer 2011 (2months): Internship Global Operations Quality &
French as mother language Compliance, and Pharmacovigilance
English fluently UCB Pharma, Brussels (Belgium)
In charge of the creation of a procedure, updates of former
Regular use of Word, Excel, Power- procedures in Regulatory Affairs and Pharmacovigilance.
point Development of regulatory knowledge.
Use of scientific search engine
Summer 2010 (2 months): Internship in a factory
Solvay, Jemeppe-sur-Sambre (Belgium)
Discovery of the manufacturing processes of the PVC. Maintenance of
the machines and supervising of some steps of the reaction.
Development of technical knowledge.
2009-2011: Internships and job of pharmacist student
Pharmacie de l’Avenue, Douai (France)
Discovery of a pharmacy, implementation of the knowledge acquired
at school.
Medicines deliverance, stock management.
Development of communication skills.
Summer 2008: Sales assistant
Promod, Douai (France)
Stock management, customers advising.
C URSUS
2011-2012: Fifth year of pharmacy, industry specialization
Université Lille2, (France)
Lectures about the different sides of the pharmaceutical industry
world.
Team work on scientific communication (dapagliflozin) and industrial
model, public presentations.
Telephone : 00 33 628 17 73 06
E-mail : melanie.tilte@yahoo.com
2007-2011: Biological and pharmaceutical sciences faculty
Université Lille2 (France)
http://www.linkedin.com/profile/view?
Common lectures, pharmaceuticals knowledge.
id=132482825&trk=tab_pro
PERSONAL INTERESTS
230, chemin de la Collose Involvement in « StopSIDA »: presentations in secondary schools about
59000 LILLE AIDS, annual calendar
FRANCE Competitive gymnastics for ten years then sports regularly
Novels and various press reading
Cinema, television, Web.
Driver’s license since 2007